The Journal of Infectious Diseases 2024

6 papers
The 2024 edition of The Journal of Infectious Diseases featured research focused on the evolving landscape of SARS-CoV-2 and global health threats. Studies examined the clinical severity of emerging variants, such as JN.1 and HV.1, noting a reduced likelihood of hospitalization compared to the EG.5 variant. Additionally, researchers investigated the relationship between SARS-CoV-2 viral load and vaccination status across multiple phase 3 trials. Antimicrobial resistance remained a significant theme, with investigations into regional outbreaks of carbapenemase-producing Enterobacterales carrying bla IMP and mcr-9 genes, as well as the epidemiological success of drug-resistant Mycobacterium tuberculosis lineages in Western India. The journal also published findings on the innate and cellular immune responses to Ebola vaccines and the mechanisms of thrombocytopenia in Severe Fever with Thrombocytopenia Syndrome. Notable contributors to these studies included Elizabeth T. Cirulli, Jason D. Goldman, and James T. Lu.

Top Research Directions

The 3 research directions with The Journal of Infectious Diseases 2024 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Mechanics of Plasmid Mediated Resistance Dissemination116.7%
2Modeling the Dynamics of Asymptomatic Pathogen Transmission116.7%
3The Downstream Consequences of Dataset Incompleteness116.7%

Download all directions as CSV

Institutions

Institutions credited by The Journal of Infectious Diseases 2024 papers: a paper credits every institution named in its affiliations, once. 10 institutions share 1 credited papers.

#InstitutionPapersShare20232023 rank
101jap5s81 1100.0%0—
2030nd5313 1100.0%0—
30331zs648 1100.0%0—
405jg8yp15 1100.0%0—
5Imperial College Healthcare NHS Trust 1100.0%0—
6Imperial College London 1100.0%0—
7Mahidol University 1100.0%0—
8UK Health Security Agency 1100.0%0—
9University of Edinburgh 1100.0%0—
10University of Warwick 1100.0%0—

Download all institutions as CSV

About this data

Papers. The Journal of Infectious Diseases 2024 lists 6 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 6 papers (16.7%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Journal of Infectious Diseases 2024”, https://lacuna.tiptreesystems.com/venue/the-journal-of-infectious-diseases/2024.

Top Authors

AuthorPapers
Hang Dai1
Mauricio Barahona1
Peter B. Gilbert1
Rodolphe Thiébaut1

Papers

Title
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials
Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India
Innate and Cellular Immune Response to the Ebola Vaccine Ad26.ZEBOV, MVA-BN-Filo: An Ancillary Study of the EBL2001 Phase 2 Trial
Integrated Analysis of Patient Networks and Plasmid Genomes to Investigate a Regional, Multispecies Outbreak of Carbapenemase-Producing Enterobacterales Carrying Both bla IMP and mcr-9 G
Reduced Likelihood of Hospitalization With the JN.1 or HV.1 Severe Acute Respiratory Syndrome Coronavirus 2 Variants Compared With the EG.5 Variant
Thrombocytopenia in Severe Fever with Thrombocytopenia Syndrome Due to Platelets With Altered Function Undergoing Cell Death Pathways